Follows people treated for narrowing of the left main heart artery
Follows adults with left main coronary artery narrowing treated with medicine, stents or bypass surgery.
Key facts
- Who runs it
- Seung-Jung Park
- Where
- Anyang, Bucheon-si, Busan, Cheonan, Cheongju-si, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Inchon, Jeonju, Kwangju, Pusan, Seongnam, Seoul, Suwon, Ulsan, and Wŏnju, South KoreaSee the 38 sitesAlso in 4 other countries, 4 sites
- Trial code
- Registry title
- Observational Study for Left Main Disease Treatment
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- Jul 2007
- Expected to end
- Dec 2033
- Type of study
- Observational
- Record updated
- 15 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a significant narrowing of the left main coronary artery that is not protected by a bypass graft. It observes how they do over time with medicine, stents or bypass surgery.
- Age
- Older than 18 years
- Sex
- All sexes can join
- Disease stage
- Significant unprotected left main stenosis (narrowing greater than 50% by visual estimation). The artery counts as unprotected if there are no open bypass grafts to the left anterior descending or left circumflex artery. No limits on other clinical or lesion features.
Main reasons for not taking part
- Protected left main stenosis
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Significant unprotected left main stenosis (>50% by visual estimation); The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery
- No limitation of clinical or lesion characteristics
- Age >18 years
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site
Who cannot take part
- Protected left main stenosis
Where in South Korea
Also in 4 other countries, 4 sites
- Hallym University Medical CenterAnyang, South KoreaContact: Woo-jung Park, MDTaking people
- Soonchunhyang University Hospital, BuchenBucheon-si, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- The Catholic University of Korea, Bucheon St. Mary's HospitalBucheon-si, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Inje University Busan Paik HospitalBusan, South KoreaContact: Tae-hyun Yang, MDTaking people
- Soonchunhyang University Hospital CheonanCheonan, South KoreaContact: Won Yong ShinTaking people
- St.Mary's Catholic Medical CenterCheongju-si, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Daegu Catholic University Medical CenterDaegu, South KoreaContact: Kee-sik Kim, MDTaking people
- Keimyung University - Dongsan Medical CenterDaegu, South KoreaContact: Seung-ho Hur, MDTaking people
- Yeungnam University Medical CenterDaegu, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Chungnam National University HospitalDaejeon, South KoreaContact: Jin-ok Jeong, MDTaking people
- The Catholic University of Korea, Daejeon ST.Mary's HospitalDaejeon, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Gangneung Asan Medical CenterGangneung, South KoreaContact: Sang-sig Cheong, MDTaking people
- Chonnam National University HospitalGwangju, South KoreaContact: Myung-ho Jeong, MDTaking people
- National Health Insurance Service Ilsan HospitalIlsan, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- St.Mary's Catholic Medical CenterInchon, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Chonbuk National University HospitalJeonju, South KoreaContact: Jei-keon Chae, MDTaking people
- Presbyterian Medical CenterJeonju, South KoreaContact: Jay-young Rhew, MDTaking people
- Kwangju Christian HospitalKwangju, South KoreaContact: Seung-uk Lee, MDTaking people
- Pusan Natioanal University HospitalPusan, South KoreaContact: June-Hong Kim, MD, PhDTaking people
- Bundang CHA HospitalSeongnam, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Asan Medical CenterSeoul, South KoreaContact: Seung-jung Park, MDTaking people
- Dongguk University Medical CenterSeoul, South KoreaContact: Deuk-young Nah, MDTaking people
- Gangnam Severance HospitalSeoul, South KoreaContact: Hyuck-moon Kwon, MDTaking people
- Kangbuk Samsung HospitalSeoul, South KoreaContact: Byung-jin Kim, MDTaking people
- Kangdong Sacred Heart HospitalSeoul, South KoreaContact: Kyoo-rok Han, MDTaking people
- Korea University Anam HospitalSeoul, South KoreaContact: Do-sun Lim, MDTaking people
- Korea University Guro HospitalSeoul, South KoreaContact: Seung-un Na, MDTaking people
- Seoul National University Boramae Medical CenterSeoul, South KoreaContact: Woo-young Chung, MDTaking people
- Seoul National University HospitalSeoul, South KoreaContact: Hyo-Soo Kim, MD, PhDTaking people
- Seoul Veterans HospitalSeoul, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- St.Mary's Catholic Medical CenterSeoul, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- The Catholic University of Korea Yeouido St. Mary's HospitalSeoul, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- The Catholic University of Korea, St. Paul's hospitalSeoul, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Yonsei University Medical CenterSeoul, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- The Catholic University of Korea St. Vincent's HospitalSuwon, South KoreaContact: Keon-woong Moon, MDTaking people
- Ajou University HospitalSuwon, South KoreaContact: Seung-Jung Park, MD, PhDNo longer taking part
- Ulsan University HospitalUlsan, South KoreaContact: Sang-Gon Lee, MD, PhDTaking people
- Wonju Christian HospitalWŏnju, South KoreaContact: Junghan YoonTaking people
About the trial
What the trial wants to find out
The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the "real world" daily practice.
The group in the trial
- Left Main disease
Consecutive patients with unprotected LMCA diseases at participating centers will be evaluated for the entry into the study.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT
- Plain-language title
- Follows people treated for narrowing of the left main heart arteryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Long-term outcomes after percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting for left main coronary artery disease: a prospective analysis of the multicentre IRIS-MAIN registry.Lancet (London, England), 2026
- Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease.JACC. Cardiovascular interventions, 2024
- Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease.Revista espanola de cardiologia (English ed.), 2023
- Comparison of Long-Term Outcomes Following Coronary Revascularization in Men-vs-Women with Unprotected Left Main Disease.The American journal of cardiology, 2021
- Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction.Journal of the American College of Cardiology, 2020
- Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.Circulation. Cardiovascular interventions, 2017
- Record updated
- 15 October 2026